Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis

Detalhes bibliográficos
Autor(a) principal: Oliveira, Cláudio Bruno Silva de
Data de Publicação: 2016
Outros Autores: Meurer, Ywlliane S.R., Medeiros, Thales L., Pohlit, Adrian Martin, Silva, Murilo Vieira, Mineo, Tiago W.P., Andrade Neto, Valter Ferreira de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional do INPA
Texto Completo: https://repositorio.inpa.gov.br/handle/1/15813
Resumo: Toxoplasmosis is caused by Toxoplasma gondii, an obligatory intracellular protozoan. Normally benign, T. gondii infections can cause devastating disease in immunosuppressed patients and through congenital infection of newborn babies. Few prophylactic and therapeutic drugs are available to treat these infections. The goal of the present study was to assess the anti-Toxoplasma effects in a congenital and noncongenital model of toxoplasmosis (using ME49 strain), besides assessing immunological changes, in vitro cytotoxicity, and in vivo acute toxicity of commercial estragole and thymol. The congenital experimental model was used with intermediate stages of maternal infection. The serum levels of immunoglobulin (Ig)M, IgG, interleukin (IL)-10, IL-12, and interferon-gamma (IFN-γ) were quantified from infected and treated C57Bl/6 mice. Estragole and thymol respectively exhibited low to moderate in vivo toxicity and cytotoxicity. Animals treated with estragole showed high IFN-γ and strong type 1 helper T cell response. Both compounds were active against T. gondii ME49 strain. Furthermore, orally administered estragole in infected pregnant mice improved the weight of offspring compared with untreated controls. Subcutaneous administration of both compounds also increased the weight of mouse offspring born to infected mothers, compared with untreated controls. Estragole and thymol display important anti-Toxoplasma activity. Further studies are needed to elucidate the mechanism of action of these compounds. © American Society of Parasitologists 2016.
id INPA-2_f91ded5b4fea6814b7f22c3c7b3e9601
oai_identifier_str oai:repositorio:1/15813
network_acronym_str INPA-2
network_name_str Repositório Institucional do INPA
repository_id_str
spelling Oliveira, Cláudio Bruno Silva deMeurer, Ywlliane S.R.Medeiros, Thales L.Pohlit, Adrian MartinSilva, Murilo VieiraMineo, Tiago W.P.Andrade Neto, Valter Ferreira de2020-05-19T13:43:48Z2020-05-19T13:43:48Z2016https://repositorio.inpa.gov.br/handle/1/1581310.1645/15-848Toxoplasmosis is caused by Toxoplasma gondii, an obligatory intracellular protozoan. Normally benign, T. gondii infections can cause devastating disease in immunosuppressed patients and through congenital infection of newborn babies. Few prophylactic and therapeutic drugs are available to treat these infections. The goal of the present study was to assess the anti-Toxoplasma effects in a congenital and noncongenital model of toxoplasmosis (using ME49 strain), besides assessing immunological changes, in vitro cytotoxicity, and in vivo acute toxicity of commercial estragole and thymol. The congenital experimental model was used with intermediate stages of maternal infection. The serum levels of immunoglobulin (Ig)M, IgG, interleukin (IL)-10, IL-12, and interferon-gamma (IFN-γ) were quantified from infected and treated C57Bl/6 mice. Estragole and thymol respectively exhibited low to moderate in vivo toxicity and cytotoxicity. Animals treated with estragole showed high IFN-γ and strong type 1 helper T cell response. Both compounds were active against T. gondii ME49 strain. Furthermore, orally administered estragole in infected pregnant mice improved the weight of offspring compared with untreated controls. Subcutaneous administration of both compounds also increased the weight of mouse offspring born to infected mothers, compared with untreated controls. Estragole and thymol display important anti-Toxoplasma activity. Further studies are needed to elucidate the mechanism of action of these compounds. © American Society of Parasitologists 2016.Volume 102, Número 3, Pags. 369-376Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccessEstragoleGamma InterferonImmunoglobulin GImmunoglobulin MInterleukin-10Interleukin-12ThymolAnisole DerivativeAntiinfective AgentCytokineEstragoleImmunoglobulin GImmunoglobulin MProtozoon AntibodyThymolAnti-microbial ActivityBody MassCells And Cell ComponentsDisease TreatmentDrugImmune ResponseImmunoassayInfectious DiseasePhenolic CompoundPregnancyProtozoanRodentToxicityAcute ToxicityAnimals ExperimentAnimals ModelComparative StudyCongenital ToxoplasmosisControlled StudyCytotoxicityCytotoxicity AssayDrug MechanismEnzyme-linked Immunosorbent AssayFemaleHela Cell LineHelper CellHep-g2 Cell LineHumanHuman CellIn Vitro StudyIn Vivo StudyMouseNonhumanSurvival RateToxicity TestingToxoplasma GondiiToxoplasmosisAnimalsToxoplasmosis, AnimalsBloodBrainC57bl MouseCell CultureDrug EffectHep-g2 Cell LineImmunologyParasitologyPeritoneum MacrophagePregnancyPregnancy ComplicationToxoplasmaAnimalsiaMurinaeMusProtozoaToxoplasmaToxoplasma GondiiAnimalAnisolesAnti-infective AgentsAntibodies, ProtozoanBrainCells, CulturedCytokinesFemaleHela CellsHep G2 CellsHumansImmunoglobulin GImmunoglobulin MMacrophages, PeritonealMiceMice, Inbred C57blPregnancyPregnancy Complications, ParasiticThymolToxoplasmaToxoplasmosis, AnimalsAnti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleJournal of Parasitologyengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf241837https://repositorio.inpa.gov.br/bitstream/1/15813/1/artigo-inpa.pdf31fcf18a55eeec7ad3a721a2b60d9d28MD511/158132020-05-19 10:18:11.735oai:repositorio:1/15813Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-05-19T14:18:11Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.en.fl_str_mv Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
title Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
spellingShingle Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
Oliveira, Cláudio Bruno Silva de
Estragole
Gamma Interferon
Immunoglobulin G
Immunoglobulin M
Interleukin-10
Interleukin-12
Thymol
Anisole Derivative
Antiinfective Agent
Cytokine
Estragole
Immunoglobulin G
Immunoglobulin M
Protozoon Antibody
Thymol
Anti-microbial Activity
Body Mass
Cells And Cell Components
Disease Treatment
Drug
Immune Response
Immunoassay
Infectious Disease
Phenolic Compound
Pregnancy
Protozoan
Rodent
Toxicity
Acute Toxicity
Animals Experiment
Animals Model
Comparative Study
Congenital Toxoplasmosis
Controlled Study
Cytotoxicity
Cytotoxicity Assay
Drug Mechanism
Enzyme-linked Immunosorbent Assay
Female
Hela Cell Line
Helper Cell
Hep-g2 Cell Line
Human
Human Cell
In Vitro Study
In Vivo Study
Mouse
Nonhuman
Survival Rate
Toxicity Testing
Toxoplasma Gondii
Toxoplasmosis
Animals
Toxoplasmosis, Animals
Blood
Brain
C57bl Mouse
Cell Culture
Drug Effect
Hep-g2 Cell Line
Immunology
Parasitology
Peritoneum Macrophage
Pregnancy
Pregnancy Complication
Toxoplasma
Animalsia
Murinae
Mus
Protozoa
Toxoplasma
Toxoplasma Gondii
Animal
Anisoles
Anti-infective Agents
Antibodies, Protozoan
Brain
Cells, Cultured
Cytokines
Female
Hela Cells
Hep G2 Cells
Humans
Immunoglobulin G
Immunoglobulin M
Macrophages, Peritoneal
Mice
Mice, Inbred C57bl
Pregnancy
Pregnancy Complications, Parasitic
Thymol
Toxoplasma
Toxoplasmosis, Animals
title_short Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
title_full Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
title_fullStr Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
title_full_unstemmed Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
title_sort Anti-Toxoplasma Activity of Estragole and Thymol in Murine Models of Congenital and Noncongenital Toxoplasmosis
author Oliveira, Cláudio Bruno Silva de
author_facet Oliveira, Cláudio Bruno Silva de
Meurer, Ywlliane S.R.
Medeiros, Thales L.
Pohlit, Adrian Martin
Silva, Murilo Vieira
Mineo, Tiago W.P.
Andrade Neto, Valter Ferreira de
author_role author
author2 Meurer, Ywlliane S.R.
Medeiros, Thales L.
Pohlit, Adrian Martin
Silva, Murilo Vieira
Mineo, Tiago W.P.
Andrade Neto, Valter Ferreira de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Cláudio Bruno Silva de
Meurer, Ywlliane S.R.
Medeiros, Thales L.
Pohlit, Adrian Martin
Silva, Murilo Vieira
Mineo, Tiago W.P.
Andrade Neto, Valter Ferreira de
dc.subject.eng.fl_str_mv Estragole
Gamma Interferon
Immunoglobulin G
Immunoglobulin M
Interleukin-10
Interleukin-12
Thymol
Anisole Derivative
Antiinfective Agent
Cytokine
Estragole
Immunoglobulin G
Immunoglobulin M
Protozoon Antibody
Thymol
Anti-microbial Activity
Body Mass
Cells And Cell Components
Disease Treatment
Drug
Immune Response
Immunoassay
Infectious Disease
Phenolic Compound
Pregnancy
Protozoan
Rodent
Toxicity
Acute Toxicity
Animals Experiment
Animals Model
Comparative Study
Congenital Toxoplasmosis
Controlled Study
Cytotoxicity
Cytotoxicity Assay
Drug Mechanism
Enzyme-linked Immunosorbent Assay
Female
Hela Cell Line
Helper Cell
Hep-g2 Cell Line
Human
Human Cell
In Vitro Study
In Vivo Study
Mouse
Nonhuman
Survival Rate
Toxicity Testing
Toxoplasma Gondii
Toxoplasmosis
Animals
Toxoplasmosis, Animals
Blood
Brain
C57bl Mouse
Cell Culture
Drug Effect
Hep-g2 Cell Line
Immunology
Parasitology
Peritoneum Macrophage
Pregnancy
Pregnancy Complication
Toxoplasma
Animalsia
Murinae
Mus
Protozoa
Toxoplasma
Toxoplasma Gondii
Animal
Anisoles
Anti-infective Agents
Antibodies, Protozoan
Brain
Cells, Cultured
Cytokines
Female
Hela Cells
Hep G2 Cells
Humans
Immunoglobulin G
Immunoglobulin M
Macrophages, Peritoneal
Mice
Mice, Inbred C57bl
Pregnancy
Pregnancy Complications, Parasitic
Thymol
Toxoplasma
Toxoplasmosis, Animals
topic Estragole
Gamma Interferon
Immunoglobulin G
Immunoglobulin M
Interleukin-10
Interleukin-12
Thymol
Anisole Derivative
Antiinfective Agent
Cytokine
Estragole
Immunoglobulin G
Immunoglobulin M
Protozoon Antibody
Thymol
Anti-microbial Activity
Body Mass
Cells And Cell Components
Disease Treatment
Drug
Immune Response
Immunoassay
Infectious Disease
Phenolic Compound
Pregnancy
Protozoan
Rodent
Toxicity
Acute Toxicity
Animals Experiment
Animals Model
Comparative Study
Congenital Toxoplasmosis
Controlled Study
Cytotoxicity
Cytotoxicity Assay
Drug Mechanism
Enzyme-linked Immunosorbent Assay
Female
Hela Cell Line
Helper Cell
Hep-g2 Cell Line
Human
Human Cell
In Vitro Study
In Vivo Study
Mouse
Nonhuman
Survival Rate
Toxicity Testing
Toxoplasma Gondii
Toxoplasmosis
Animals
Toxoplasmosis, Animals
Blood
Brain
C57bl Mouse
Cell Culture
Drug Effect
Hep-g2 Cell Line
Immunology
Parasitology
Peritoneum Macrophage
Pregnancy
Pregnancy Complication
Toxoplasma
Animalsia
Murinae
Mus
Protozoa
Toxoplasma
Toxoplasma Gondii
Animal
Anisoles
Anti-infective Agents
Antibodies, Protozoan
Brain
Cells, Cultured
Cytokines
Female
Hela Cells
Hep G2 Cells
Humans
Immunoglobulin G
Immunoglobulin M
Macrophages, Peritoneal
Mice
Mice, Inbred C57bl
Pregnancy
Pregnancy Complications, Parasitic
Thymol
Toxoplasma
Toxoplasmosis, Animals
description Toxoplasmosis is caused by Toxoplasma gondii, an obligatory intracellular protozoan. Normally benign, T. gondii infections can cause devastating disease in immunosuppressed patients and through congenital infection of newborn babies. Few prophylactic and therapeutic drugs are available to treat these infections. The goal of the present study was to assess the anti-Toxoplasma effects in a congenital and noncongenital model of toxoplasmosis (using ME49 strain), besides assessing immunological changes, in vitro cytotoxicity, and in vivo acute toxicity of commercial estragole and thymol. The congenital experimental model was used with intermediate stages of maternal infection. The serum levels of immunoglobulin (Ig)M, IgG, interleukin (IL)-10, IL-12, and interferon-gamma (IFN-γ) were quantified from infected and treated C57Bl/6 mice. Estragole and thymol respectively exhibited low to moderate in vivo toxicity and cytotoxicity. Animals treated with estragole showed high IFN-γ and strong type 1 helper T cell response. Both compounds were active against T. gondii ME49 strain. Furthermore, orally administered estragole in infected pregnant mice improved the weight of offspring compared with untreated controls. Subcutaneous administration of both compounds also increased the weight of mouse offspring born to infected mothers, compared with untreated controls. Estragole and thymol display important anti-Toxoplasma activity. Further studies are needed to elucidate the mechanism of action of these compounds. © American Society of Parasitologists 2016.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2020-05-19T13:43:48Z
dc.date.available.fl_str_mv 2020-05-19T13:43:48Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.inpa.gov.br/handle/1/15813
dc.identifier.doi.none.fl_str_mv 10.1645/15-848
url https://repositorio.inpa.gov.br/handle/1/15813
identifier_str_mv 10.1645/15-848
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Volume 102, Número 3, Pags. 369-376
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Journal of Parasitology
publisher.none.fl_str_mv Journal of Parasitology
dc.source.none.fl_str_mv reponame:Repositório Institucional do INPA
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Repositório Institucional do INPA
collection Repositório Institucional do INPA
bitstream.url.fl_str_mv https://repositorio.inpa.gov.br/bitstream/1/15813/1/artigo-inpa.pdf
bitstream.checksum.fl_str_mv 31fcf18a55eeec7ad3a721a2b60d9d28
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv
_version_ 1797064393639329792